Process View
The network for 'dna damage response signal transduction by p53 class mediator' in your query organism is displayed on the left, if relationships are supported by the integrated data. Moving any of the genes in that network will simultaneously update the homologs in the networks displayed to the right (if they exist). Additionally, hovering over any nodes will highlight the identified functionally similar homologs in the other networks. Last, the bar above the networks allows you to remove/add additional organisms. Simily drag and drop the organism names in the desired order.
A cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage.
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
Trp53 | transformation related protein 53 | 1.000 | |
Mdm2 | transformed mouse 3T3 cell double minute 2 | 0.996 | |
Pten | phosphatase and tensin homolog | 0.976 | |
Rb1 | retinoblastoma 1 | 0.955 | |
Brca1 | breast cancer 1 | 0.896 | |
Cdkn1b | cyclin-dependent kinase inhibitor 1B | 0.883 | |
Apc | adenomatosis polyposis coli | 0.698 | |
Kras | v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | 0.688 | |
Kit | kit oncogene | 0.525 | |
Tgfb1 | transforming growth factor, beta 1 | 0.523 | |
Mdm4 | transformed mouse 3T3 cell double minute 4 | 0.456 | |
Skil | SKI-like | 0.401 | |
Ctnnb1 | catenin (cadherin associated protein), beta 1 | 0.329 | |
Atm | ataxia telangiectasia mutated homolog (human) | 0.251 | |
Nbn | nibrin | 0.246 | |
Thbs1 | thrombospondin 1 | 0.209 | |
Hprt | hypoxanthine guanine phosphoribosyl transferase | 0.192 | |
Brca2 | breast cancer 2 | 0.167 | |
Cdkn2a | cyclin-dependent kinase inhibitor 2A | 0.162 | |
Sirt1 | sirtuin 1 (silent mating type information regulation 2, homolog) 1 (S. cerevisiae) | 0.156 | |
Kitl | kit ligand | 0.150 | |
Braf | Braf transforming gene | 0.141 | |
Smc1a | structural maintenance of chromosomes 1A | 0.135 | |
Arid1b | AT rich interactive domain 1B (SWI-like) | 0.133 | |
Ep300 | E1A binding protein p300 | 0.120 | |
Cdkn1a | cyclin-dependent kinase inhibitor 1A (P21) | 0.111 | |
H2-Aa | histocompatibility 2, class II antigen A, alpha | 0.092 | |
Smad3 | MAD homolog 3 (Drosophila) | 0.088 | |
Smarca4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.088 | |
2500003M10Rik | RIKEN cDNA 2500003M10 gene | 0.083 | |
Cyld | cylindromatosis (turban tumor syndrome) | 0.082 | |
Hif1a | hypoxia inducible factor 1, alpha subunit | 0.080 | |
H2-Eb1 | histocompatibility 2, class II antigen E beta | 0.080 | |
Daxx | Fas death domain-associated protein | 0.080 | |
Mecp2 | methyl CpG binding protein 2 | 0.078 | |
Ccnd1 | cyclin D1 | 0.076 | |
E2f1 | E2F transcription factor 1 | 0.071 | |
En1 | engrailed 1 | 0.069 | |
Snai1 | snail homolog 1 (Drosophila) | 0.069 | |
Nfkb2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49/p100 | 0.067 | |
Stat3 | signal transducer and activator of transcription 3 | 0.066 | |
Meox2 | mesenchyme homeobox 2 | 0.063 | |
Abl1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.063 | |
Dicer1 | Dicer1, Dcr-1 homolog (Drosophila) | 0.062 | |
Mcl1 | myeloid cell leukemia sequence 1 | 0.061 | |
Evl | Ena-vasodilator stimulated phosphoprotein | 0.061 | |
Enah | enabled homolog (Drosophila) | 0.060 | |
Icam1 | intercellular adhesion molecule 1 | 0.060 | |
Relb | avian reticuloendotheliosis viral (v-rel) oncogene related B | 0.059 | |
Smad4 | MAD homolog 4 (Drosophila) | 0.058 | |
Cdkn2c | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | 0.055 | |
Socs1 | suppressor of cytokine signaling 1 | 0.053 | |
Cdk4 | cyclin-dependent kinase 4 | 0.051 | |
Msh2 | mutS homolog 2 (E. coli) | 0.051 | |
Ar | androgen receptor | 0.051 | |
Ets1 | E26 avian leukemia oncogene 1, 5' domain | 0.050 | |
Myc | myelocytomatosis oncogene | 0.049 | |
Irf4 | interferon regulatory factor 4 | 0.047 | |
Gtse1 | G two S phase expressed protein 1 | 0.047 | |
Gli3 | GLI-Kruppel family member GLI3 | 0.047 | |
Kdm2b | lysine (K)-specific demethylase 2B | 0.046 | |
Ptch1 | patched homolog 1 | 0.046 | |
Mybl2 | myeloblastosis oncogene-like 2 | 0.045 | |
Notch1 | Notch gene homolog 1 (Drosophila) | 0.045 | |
Rbl1 | retinoblastoma-like 1 (p107) | 0.044 | |
Jak3 | Janus kinase 3 | 0.044 | |
Prkar1a | protein kinase, cAMP dependent regulatory, type I, alpha | 0.043 | |
H2-DMa | histocompatibility 2, class II, locus DMa | 0.043 | |
Foxo3 | forkhead box O3 | 0.041 | |
Runx1 | runt related transcription factor 1 | 0.041 | |
Mmp9 | matrix metallopeptidase 9 | 0.040 | |
Dok1 | docking protein 1 | 0.038 | |
Ccl2 | chemokine (C-C motif) ligand 2 | 0.038 | |
Kif19a | kinesin family member 19A | 0.037 | |
Gnaq | guanine nucleotide binding protein, alpha q polypeptide | 0.036 | |
Rnf38 | ring finger protein 38 | 0.035 | |
Polr2a | polymerase (RNA) II (DNA directed) polypeptide A | 0.035 | |
Smad2 | MAD homolog 2 (Drosophila) | 0.035 | |
Tnf | tumor necrosis factor | 0.035 | |
Nf1 | neurofibromatosis 1 | 0.034 | |
Tnfrsf4 | tumor necrosis factor receptor superfamily, member 4 | 0.033 | |
Tsc1 | tuberous sclerosis 1 | 0.033 | |
Bcl2l11 | BCL2-like 11 (apoptosis facilitator) | 0.033 | |
Ep400 | E1A binding protein p400 | 0.032 | |
S1pr2 | sphingosine-1-phosphate receptor 2 | 0.032 | |
Tcf7l2 | transcription factor 7-like 2, T-cell specific, HMG-box | 0.031 | |
Chst8 | carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8 | 0.030 | |
Smn1 | survival motor neuron 1 | 0.030 | |
Wdr77 | WD repeat domain 77 | 0.030 | |
Smc3 | structural maintenace of chromosomes 3 | 0.030 | |
Smarcd1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 | 0.030 | |
Arid1a | AT rich interactive domain 1A (SWI-like) | 0.030 | |
Abl2 | v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene) | 0.030 | |
Smarcc1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 | 0.030 | |
Itgb1 | integrin beta 1 (fibronectin receptor beta) | 0.030 | |
Ythdf1 | YTH domain family 1 | 0.029 | |
Irf1 | interferon regulatory factor 1 | 0.029 | |
Vhl | von Hippel-Lindau tumor suppressor | 0.029 | |
Stk11 | serine/threonine kinase 11 | 0.029 | |
Mapk8 | mitogen-activated protein kinase 8 | 0.028 |
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
p53 | CG33336 gene product from transcript CG33336-RB | 0.013 | |
CtBP | C-terminal Binding Protein | 0.012 | |
Gap1 | GTPase-activating protein 1 | 0.011 | |
imd | immune deficiency | 0.011 | |
pan | pangolin | 0.011 | |
Sir2 | CG5216 gene product from transcript CG5216-RA | 0.011 | |
Liprin-alpha | CG11199 gene product from transcript CG11199-RB | 0.011 |
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
BRCA1 | breast cancer 1, early onset | 1.000 | |
CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.983 | |
PPP2CA | protein phosphatase 2, catalytic subunit, alpha isozyme | 0.977 | |
CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.977 | |
ATM | ataxia telangiectasia mutated | 0.976 | |
TP53 | tumor protein p53 | 0.951 | |
PPP2R5C | protein phosphatase 2, regulatory subunit B', gamma | 0.940 | |
CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.923 | |
CREBBP | CREB binding protein | 0.910 | |
NBN | nibrin | 0.904 | |
RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.900 | |
XIAP | X-linked inhibitor of apoptosis | 0.899 | |
CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0.838 | |
BCL2 | B-cell CLL/lymphoma 2 | 0.780 | |
MAPK1 | mitogen-activated protein kinase 1 | 0.774 | |
E2F7 | E2F transcription factor 7 | 0.766 | |
REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.738 | |
MRE11A | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) | 0.727 | |
CASP2 | caspase 2, apoptosis-related cysteine peptidase | 0.712 | |
E2F8 | E2F transcription factor 8 | 0.689 | |
PML | promyelocytic leukemia | 0.683 | |
CDK2 | cyclin-dependent kinase 2 | 0.671 | |
RAD51 | RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae) | 0.666 | |
FAS | Fas (TNF receptor superfamily, member 6) | 0.585 | |
H2AFX | H2A histone family, member X | 0.581 | |
MAPK8 | mitogen-activated protein kinase 8 | 0.572 | |
CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.552 | |
EP300 | E1A binding protein p300 | 0.549 | |
MDC1 | mediator of DNA-damage checkpoint 1 | 0.535 | |
BCAS2 | breast carcinoma amplified sequence 2 | 0.522 | |
RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.494 | |
MAPK14 | mitogen-activated protein kinase 14 | 0.471 | |
FANCD2 | Fanconi anemia, complementation group D2 | 0.463 | |
NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.458 | |
PPP2R1B | protein phosphatase 2, regulatory subunit A, beta | 0.407 | |
TWIST1 | twist homolog 1 (Drosophila) | 0.393 | |
MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.387 | |
IER3 | immediate early response 3 | 0.384 | |
PPP2R5A | protein phosphatase 2, regulatory subunit B', alpha | 0.382 | |
GSK3B | glycogen synthase kinase 3 beta | 0.378 | |
OTUB1 | OTU domain, ubiquitin aldehyde binding 1 | 0.358 | |
CCNE1 | cyclin E1 | 0.354 | |
NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.344 | |
HIPK2 | homeodomain interacting protein kinase 2 | 0.341 | |
APAF1 | apoptotic peptidase activating factor 1 | 0.339 | |
DAXX | death-domain associated protein | 0.320 | |
MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.313 | |
CCND3 | cyclin D3 | 0.311 | |
PPM1D | protein phosphatase, Mg2+/Mn2+ dependent, 1D | 0.282 | |
PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.280 | |
NCOA3 | nuclear receptor coactivator 3 | 0.271 | |
CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.270 | |
SETD8 | SET domain containing (lysine methyltransferase) 8 | 0.262 | |
CDC5L | CDC5 cell division cycle 5-like (S. pombe) | 0.258 | |
TP53BP1 | tumor protein p53 binding protein 1 | 0.252 | |
MYH7B | myosin, heavy chain 7B, cardiac muscle, beta | 0.249 | |
RAD50 | RAD50 homolog (S. cerevisiae) | 0.248 | |
NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.242 | |
TNIP2 | TNFAIP3 interacting protein 2 | 0.240 | |
BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.239 | |
PPFIA1 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 | 0.238 | |
DDAH2 | dimethylarginine dimethylaminohydrolase 2 | 0.234 | |
UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.212 | |
RAD18 | RAD18 homolog (S. cerevisiae) | 0.211 | |
PARP1 | poly (ADP-ribose) polymerase 1 | 0.208 | |
TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.207 | |
SP110 | SP110 nuclear body protein | 0.205 | |
NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.198 | |
MLL | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) | 0.188 | |
IFI16 | interferon, gamma-inducible protein 16 | 0.185 | |
RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 | 0.181 | |
HRAS | v-Ha-ras Harvey rat sarcoma viral oncogene homolog | 0.173 | |
PPP2R1A | protein phosphatase 2, regulatory subunit A, alpha | 0.172 | |
CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.172 | |
HDAC1 | histone deacetylase 1 | 0.167 | |
SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.165 | |
PPP1CA | protein phosphatase 1, catalytic subunit, alpha isozyme | 0.163 | |
MAPK3 | mitogen-activated protein kinase 3 | 0.159 | |
CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.158 | |
MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.154 | |
LRDD | leucine-rich repeats and death domain containing | 0.146 | |
CFLAR | CASP8 and FADD-like apoptosis regulator | 0.144 | |
HNRNPM | heterogeneous nuclear ribonucleoprotein M | 0.143 | |
LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.132 | |
PLK1 | polo-like kinase 1 | 0.132 | |
HIC2 | hypermethylated in cancer 2 | 0.131 | |
UBR3 | ubiquitin protein ligase E3 component n-recognin 3 (putative) | 0.125 | |
CDC25A | cell division cycle 25 homolog A (S. pombe) | 0.121 | |
EGFR | epidermal growth factor receptor | 0.119 | |
CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.118 | |
SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.115 | |
RB1 | retinoblastoma 1 | 0.114 | |
SP100 | SP100 nuclear antigen | 0.114 | |
RUNX1 | runt-related transcription factor 1 | 0.113 | |
ITCH | itchy E3 ubiquitin protein ligase homolog (mouse) | 0.107 | |
RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.105 | |
TP53BP2 | tumor protein p53 binding protein, 2 | 0.103 | |
MAPK8IP2 | mitogen-activated protein kinase 8 interacting protein 2 | 0.099 | |
PRKCA | protein kinase C, alpha | 0.097 | |
PPP1CC | protein phosphatase 1, catalytic subunit, gamma isozyme | 0.097 |